Reverse signaling from LIGHT promotes pro-inflammatory responses in the human monocytic leukemia cell line, THP-1

•LIGHT-mediated signaling was analyzed in human macrophage cell line THP-1.•LIGHT triggering induced expression of MMP-9 and IL-8.•LIGHT triggering suppressed phagocytic activity of THP-1 cells.•ERK/PI3K/NF-κB mediated in the signaling induced by LIGHT. LIGHT is a type II transmembrane protein belon...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cellular immunology 2013-09, Vol.285 (1-2), p.10-17
Hauptverfasser: Lim, Su-Geun, Suk, Kyoungho, Lee, Won-Ha
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•LIGHT-mediated signaling was analyzed in human macrophage cell line THP-1.•LIGHT triggering induced expression of MMP-9 and IL-8.•LIGHT triggering suppressed phagocytic activity of THP-1 cells.•ERK/PI3K/NF-κB mediated in the signaling induced by LIGHT. LIGHT is a type II transmembrane protein belonging to the TNF superfamily which is involved in co-stimulation of T cells or apoptosis in tumors. In this study, the possibility of LIGHT-mediated reverse signaling was tested in the human monocytic leukemia cell line, THP-1. For stimulation of LIGHT, cells were stimulated with specific monoclonal antibody and changes in macrophage-related functions such as phagocytosis, adhesion, migration, cytokine secretion, and production of pro-inflammatory mediators were tested. Triggering of LIGHT induced production of pro-inflammatory mediators such as interleukin (IL)-8 and matrix metalloproteinase (MMP)-9 while suppressing the phagocytic activity. Utilization of signaling inhibitors and Western blot demonstrated that LIGHT activated ERK MAPK and PI3K and the major inflammatory transcription factor NF-κB. These data indicate that LIGHT-mediated signaling could modulate the macrophage activities and that successful regulation of its activity could be beneficial to the treatment of chronic inflammatory conditions where macrophages play an important role.
ISSN:0008-8749
1090-2163
DOI:10.1016/j.cellimm.2013.08.002